WT1-W10 peptide vaccine (NEC Corp/Cytlimic)

WT1-W10多肽疫苗(高知大学)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameWT1-W10 peptide vaccine (NEC Corp/Cytlimic)
Drug Alias NameWT1 W10
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNec Corp
China Registration ClassN/A

Develop Information

Active CompaniesNec CorpKochi University
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A